SEEN BUT NOT HEARD? CHILDREN IN CLINICAL TRIALS

Although a body of law relating to medical treatment of children exists, the law is relatively undeveloped regarding clinical research. In this article, I consider the implications of the Medicines for Human Use (Clinical Trials) Regulations 2004. I argue that young people's right to self-determination may not be adequately protected. In addition, I explore the implications of a 'direct positive benefit test', which may prove unduly restrictive of some types of paediatric research.